KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Accumulated Expenses: 2010-2018

Historic Other Accumulated Expenses for Idexx Laboratories (IDXX) over the last 7 years, with Mar 2018 value amounting to $65.8 million.

  • Idexx Laboratories' Other Accumulated Expenses rose 18.53% to $65.8 million in Q1 2018 from the same period last year, while for Mar 2018 it was $65.8 million, marking a year-over-year increase of 18.53%. This contributed to the annual value of $64.4 million for FY2017, which is 10.49% down from last year.
  • Latest data reveals that Idexx Laboratories reported Other Accumulated Expenses of $65.8 million as of Q1 2018, which was up 2.18% from $64.4 million recorded in Q4 2017.
  • In the past 5 years, Idexx Laboratories' Other Accumulated Expenses ranged from a high of $72.0 million in Q4 2016 and a low of $44.6 million during Q1 2014.
  • Its 3-year average for Other Accumulated Expenses is $62.3 million, with a median of $61.3 million in 2017.
  • In the last 5 years, Idexx Laboratories' Other Accumulated Expenses surged by 38.03% in 2015 and then decreased by 11.34% in 2017.
  • Over the past 5 years, Idexx Laboratories' Other Accumulated Expenses (Quarterly) stood at $55.7 million in 2014, then increased by 17.99% to $65.7 million in 2015, then increased by 9.62% to $72.0 million in 2016, then dropped by 10.49% to $64.4 million in 2017, then rose by 18.53% to $65.8 million in 2018.
  • Its last three reported values are $65.8 million in Q1 2018, $64.4 million for Q4 2017, and $60.8 million during Q3 2017.